Transcriptional changes occur presymptomatically and throughout Huntington's Disease (HD), 3 motivating the study of transcriptional regulatory networks (TRNs) in HD. We reconstructed a 4 genome-scale model for the target genes of 718 TFs in the mouse striatum by integrating a model 5 of the genomic binding sites with transcriptome profiling of striatal tissue from HD mouse 6 models. We identified 48 differentially expressed TF-target gene modules associated with age-7
1 the mouse striatum, combining publicly available DNase-seq with brain transcriptomics data HD 2 mouse models. We identified 48 core TFs whose predicted target genes were overrepresented 3 among differentially expressed genes in at least five of fifteen conditions defined by a mouse's 4 age and Htt allele, and we replicated the predicted core TFs and differential gene expression 5 associations in multiple datasets from HD mouse models and from HD cases and controls. Based 6 on the gene expression signature of SMAD3 and its predicted target genes, we hypothesized that 7
SMAD3 is a core regulator of early gene expression changes in HD. Using chromatin 8
immunoprecipitation and deep sequencing (ChIP-seq), we demonstrate Htt-allele-dependent 9 changes in SMAD3 occupancy and down-regulation of SMAD3 target genes in mouse brain 10 tissue. In conclusion, the results from our TRN analysis and ChIP-seq studies of HD reveal new 11
insights into transcription factor drivers of complex gene expression changes in this 12 neurodegenerative disease. 13 14
Results
16
A genome-scale transcriptional regulatory network model of the mouse striatum. 17 18
We reconstructed a model of TF-target gene interactions in the mouse striatum by 19 integrating information about transcription factor binding sites (TFBSs) with evidence from gene 20 co-expression in the mouse striatum ( Fig. 1a ). 21 We predicted the binding sites for 871 TFs in the mouse genome using digital genomic 22
footprinting. We identified footprints in DNase-seq data from 23 mouse tissues (Yue et al, 23 2014), using Wellington (Piper et al, 2013) . Footprints are defined as short genomic regions with 24 reduced accessibility to the DNase-I enzyme in at least one tissue. Our goal in combining 25
DNase-seq data from multiple tissues was to reconstruct a single TFBS model that could make 26 useful predictions about TF target genes, even in conditions for which DNase-seq data were not 27 available. We identified 3,242,454 DNase-I footprints. Genomic footprints are often indicative of 28 occupancy by a DNA-binding protein. We scanned these footprints for 2,547 sequence motifs 29 from TRANSFAC (Matys et al, 2006) , JASPAR (Mathelier et al, 2014) , UniProbe (Hume et al, 30 2015), and high-throughput SELEX (Jolma et al, 2013) to predict binding sites for specific TFs 31
(TFBSs), and we compared these TFBSs to the locations of transcription start sites. We 32 considered a TF to be a potential regulator of a gene if it had at least one binding site within 5kb 33 of that gene's TSS. We showed previously that a 5kb region upstream and downstream of the 34 TSS maximizes target gene prediction from digital genomic footprinting of the human genome 35 (Plaisier et al, 2016) . 36
To assess the accuracy of this TFBS model, we compared our TFBS predictions to ChIP- 37 seq experiments from ENCODE (Yue et al, 2014) and ChEA (Lachmann et al, 2010 ) (SI Fig. 2 ). 38 For 50 of 52 TFs, there was significant overlap between the sets of target genes predicted by our 39
TFBS model vs. ChIP-seq (FDR < 1%). Our TFBS model had a median 78% recall of target 40 genes identified by ChIP-seq, and a median 22% precision. That is, our model identified the 41 majority of true-positive target genes but also made a large number of false-positive predictions. 42
Low precision is expected in this model, since TFs typically occupy only a subset of their 43
binding sites in a given tissue. Nonetheless, low precision indicates a need for additional filtering 44 steps to identify target genes that are relevant in a specific context. 45 We sought to identify TF-target gene interactions that are active in the mouse striatum, 1 by evaluating gene co-expression patterns in RNA-seq transcriptome profiles from the striatum 2 of 208 mice (Langfelder et al, 2016) . The general idea is that active regulation of a target gene 3 by a TF is likely to be associated with strong TF-gene co-expression, and TFBSs allow us to 4 identify direct regulatory interactions. This step also removes TFs with low expression: of the 5 871 TFs with TFBS predictions we retained as potential regulators the 718 TFs that were 6 expressed in the striatum. We fit a regression model to predict the expression of each gene based 7 on the combined expression patterns of TFs with one or more TFBSs ±5kb of that gene's 8 transcription start site. We used LASSO regularization to select the subset of TFs whose 9 expression patterns together predicted the expression of the target gene. This approach extends 10 several previous regression methods for TRN reconstruction (Friedman et al, 2010; Tibshirani, 11 1996; Bonneau et al, 2006; Haury et al, 2012 ) by introducing TFBS--based constraints. In 12 preliminary work, we considered a range of LASSO and elastic net (alpha = 0.2, 0.4, 0.6, 0.8, 13
1.0) regularization penalties and evaluated performance in five-fold cross-validation (see 14
Methods). We selected LASSO based on the highest correlation between prediction accuracy in 15 training vs. test sets. 16 We validated the predictive accuracy of our TRN model by comparing predicted vs. 17
observed expression levels of each gene. Our model explained >50% of expression variation for 18
13,009 genes in training data ( Fig. 1b ). Prediction accuracy in five-fold cross-validation was 19
nearly identical to prediction accuracy in training data. That is, genes whose expression was 20 accurately predicted in the training data were also accurately predicted in the test sets (r=0.94; 21 Fig. 1b ). Genes whose expression was not accurately predicted generally had low expression in 22
the striatum (Supplementary Information [SI] Fig. 1 ). We removed poorly predicted genes, based 23
on their training set accuracy before moving to the test set. The final TRN model contains 13,009 24 target genes regulated by 718 TFs via 176,518 interactions (SI Dataset 1). Our model predicts a 25 median of 14 TFs regulating each target gene and a median of 147 target genes per TF ( Fig.  26 1c,d). 15 TFs were predicted to regulate >1,000 target genes (SI Figure 3) . Importantly, TF-27 target gene interactions retained in our striatum-specific TRN model were enriched for genomic 28 footprints in the adult (p = 1.4e-82) and fetal (p = 2.1e-88) brain, supporting the idea that these 29
TF-target gene interactions reflect TF binding sites in the brain. 30 We defined as "TF-target gene modules" the sets of genes predicted to be direct targets of Npas1-3) and glia-specific TFs (e.g., Olig1, Olig2) (SI Fig. 4 ). These results suggest that many 37 TRN modules reflect the activities of TFs on biological processes within specific cell types. 38 39 Prediction of core TFs associated with transcriptional changes in HD mouse models. 40 41 We next sought to identify TFs that are core regulators of transcriptional changes in HD.
42
Of the 208 mice in the RNA-seq dataset used for network reconstruction, 144 were heterozygous 43 for a human HTT allele knocked into the endogenous Htt locus (Wheeler et al, 1999) , and the 44 remaining 64 mice were C57BL/6J littermate controls. Six distinct HTT alleles differing in the 45 length of the poly-Q repeat were knocked in. In humans, the shortest of these alleles --Htt Q20 --is 46 1 associated with progressively earlier onset of symptoms. We used RNA-seq data from four male 2 and four female mice of each genotype at each of three time points: 2-months-old, 6-months-old, 3 and 10-months-old. These mouse models undergo subtle age-and allele-dependent changes in 4 behavior, and all of the ages profiled precede detectable neuronal cell death (Alexandrov et al, 5
2016; Rothe et al, 2015; Carty et al, 2015) . 6 We evaluated gene expression differences between Htt Q20/+ mice and mice with each of 7 the five pathogenic HTT alleles at each time point, a total of 15 comparisons. The extent of gene 8 expression changes increased in an age-and Q-length-dependent fashion, with extensive overlap 9
between the DEGs identified in each condition (Fig. 2) . 8,985 genes showed some evidence of 10 differential expression (DEGs; p < 0.01) in at least one of the 15 conditions, of which 5,132 were 11 significant at a stringent False Discovery Rate < 1%. These results suggest that robust and 12
replicable gene expression changes occur in the striatum of these HD mouse models at ages well 13 before the onset of neuronal cell death or other overt pathology.
14
The predicted target genes of 209 TFs were overrepresented for DEGs in at least one of 15 the 15 conditions (3 ages x 5 mouse models; Fisher's exact test, p < 1e-6; SI Dataset 2).
16
Repeating this analysis in 1,000 permuted data sets indicated that enrichments at this level of 17 significance never occurred in more than four conditions. We therefore focused on a core set of 18 48 TFs whose predicted target genes were overrepresented for DEGs in five or more conditions. 19
Notably, 44 of these 48 TFs were differentially expressed (FDR < 0.01) in at least one of the 15 20
conditions (SI Fig. 4 ). We refer to these 48 TFs as core TFs.
22
Replication of core TFs in independent datasets. 23 24
We sought to replicate these associations by testing for enrichment of TF-target gene 25
modules for differentially expressed genes in independent HD-related datasets. First, we 26
conducted a meta-analysis of differentially expressed TF-target gene modules in four 27 independent microarray gene expression profiling studies of striatal tissue from HD mouse of 46 of the 48 core TFs were enriched for DEGs (meta-analysis p-value < 0.01) in the 30 microarray data. The overlap between TFs whose target genes were differentially expressed in 31
HD vs. control mice in microarray datasets and the core TFs from our primary dataset was 32 significantly greater than expected by chance (Fisher's exact test: p = 5.7e-32). These results 33
suggest that transcriptional changes in most of the core TF-target gene modules were preserved 34 across multiple datasets and mouse models of HD. 35 Next, we asked whether the target genes of core TFs were also differentially abundant at 36 the protein level. We studied quantitative proteomics data from the striatum of 64 6-month-old 37
HD knock-in mice (Langfelder et al, 2016) . These were a subset of the mice profiled with RNA-38 seq in our primary dataset. Targets of 22 of the 48 core TFs were enriched for differentially 39 abundant proteins (Fisher's exact test, p < 0.01). The overlap between TFs whose target genes 40
were differentially abundant between HD vs. wildtype mice and the core regulator TFs was 41 significantly greater than expected by chance (Fisher's exact test: p = 5.7e-20 types (Neph et al, 2012) with microarray gene expression profiles of post-mortem striatal tissue 46 1 striatum, we fit a LASSO regression model to predict the expression of each gene in human 2 striatum from the expression levels of TFs with predicted TFBSs within 5kb of its transcription 3 start sites (SI Fig. 6 ). We studied the enrichments of TF-target gene modules from this human 4 striatum TRN model for differentially expressed genes 5
We compared HD-related TF-target gene modules identified in mouse and human 6 striatum, focusing on 616 TFs with one-to-one orthology and ≥10 predicted target genes in both 7 the mouse and human striatum TRN models. We conducted a meta-analysis of two independent 8
datasets from the dorsal striatum of HD cases vs. controls (Hodges et al, 2006; Durrenberger et 9 al, 2015) to identify TF-target gene modules enriched for DEGs. Targets of 13 of the 48 core 10
TFs from mouse striatum were over-represented among differentially expressed genes in HD 11
cases vs. controls. This overlap was not statistically greater than expected by chance (odds ratio 12 = 1.79; p = 0.05). However, when we considered the broader set of 209 TF-target gene modules 13 that were enriched for differentially expressed genes in any of the 15 conditions from the 14 primary RNA-seq dataset, we found significant overlap for TF-target gene modules that were 15 down-regulated both in HD and in HD mouse models (28 shared TF-target gene modules; odds 16 ratio = 3.6, p = 5.0e-5; SI Fig. 6d ) and for TF-target gene modules that were up-regulated both in 17
HD and in HD mouse models (26 shared TF-target gene modules; odds ratio = 1.8, p = 0.02; SI 18 Fig. 6e ). The striatum is heavily degraded in late-stage HD, with many dead neurons and 19
extensive astrogliosis. Nonetheless, these results suggest that some transcriptional programs are 20
shared between the earliest stages of molecular progression (assayed in mouse models) and late 21
stages of human disease. 22
Notably, targets of 13 of the 48 core regulator TFs were enriched for differentially 23 expressed genes in all four datasets: Gli3, Irf2, Klf16, Npas2, Pax6, Rarb, Rfx2, Rxrg, Smad3, 24
Tcf12, Tef, Ubp1, and Vezf1. These 13 TFs may be especially interesting for follow-up studies. 25 26
Biological associations of core TFs. 27 28 We evaluated relationships among the 48 core TFs based on clustering and network 29
topology. Plotting TF-to-TF regulatory interactions among the 48 core TFs ( Fig. 4 ) revealed two 30
distinct TF-to-TF sub-networks, characterized by numerous positive interactions within sub-31 networks and by fewer, mostly inhibitory interactions between sub-networks. The target genes of 32
TFs in the first sub-network were predominantly down-regulated in HD, while the target genes 33
of TFs in the second module were predominantly up-regulated. Hierarchical clustering of the 48 34
core TFs based on the expression patterns of their predicted target genes revealed similar 35 groupings of TFs whose target genes were predominantly down-vs. up-regulated ( Fig. 5 ).
36
We studied the predicted target genes of each core TF to characterize possible roles for 37
these TFs in HD. Down-regulated TF-target gene modules were overrepresented for genes 38 specifically expressed in Drd1+ and Drd2+ medium spiny neurons ( Fig. 5 ). Functional 39 enrichments within these modules were mostly related to synaptic function, including metal ion 40 transmembrane transporters (targets of Npas2, p = 2.3e-4), voltage-gated ion channels (targets of 41
Mafa, p = 8.1e-4), and protein localization to cell surface (targets of Rxrg, p = 1.7e-4). These 42 network changes may be linked to synapse loss in medium spiny neurons, which is known to 43 occur in knock-in mouse models of HD (Deng et al, 2013).
44
Some up-regulated TF-target gene modules were overrepresented for genes specifically 45 expressed in oligodendrocytes or astrocytes, while others were overrepresented for genes 46 specifically expressed in neurons ( Fig. 5 ). Functional enrichments within these modules included 1
Gene Ontology terms related to apoptosis ("positive regulation of extrinsic apoptotic signaling 2 pathway via death domain receptors", targets of Wt1, p = 1.8e-4) and DNA repair (targets of 3
Runx2, "single-strand selective uracil DNA N-glycosylase activity", p = 2.0e-4). Therefore, core 4
TFs whose target genes were predominantly up-regulated may contribute to a variety of 5 pathological processes both in neurons and in glia. The number of oligodendrocytes is basally 6 increased in HD mutation carriers, while activated gliosis is thought to begin later in 7 disease progression (Vonsattel et al, 1985) . 8 An open question in the field is whether the same sequence of pathogenic events 9
underlies disease progression in juvenile-onset HD due to HTT alleles with very long poly-Q 10 tracts vs. adult-onset HD due to HTT alleles with relatively short poly-Q tracts. This question is 11
of practical relevance for modeling HD in mice, since mouse models with very long HTT alleles 12
are often used in research due to their faster rates of phenotypic progression within a two-year 13 lifespan. To address this question, we evaluated overlap between TF-target gene modules 14 activated at the earliest time points in mice with each of the five pathogenic Htt alleles in our 15
dataset. In the mice with the longest HTT alleles --Htt Q175 and Htt Q140 --the target genes of core 16
TFs first became enriched for differentially expressed genes in two-month-old mice. In mice 17
with relatively short HTT alleles -Htt Q111 , Htt Q92 and Htt Q80 --target genes of core TFs became 18
enriched for differentially expressed genes beginning in six-month-old mice. We found that eight 19 modules -the predicted target genes of IRF2, MAFA, KLF16, LMO2, NPAS2, RUNX2, RXRG, 20
and VEZF1 -were significantly enriched for DEGs in at least three of these five conditions 21
(two-month-old Htt Q175/+ , two-month-old Htt Q140/+ , six-month-old Htt Q111/ , six-month-old Htt Q92/+ , 22
and six-month-old Htt Q80/+ ). A limitation of this analysis is that all of the alleles used in this study 23
are associated with juvenile onset disease, and the extent to which these results extend to adult-24
onset alleles remains to be detemined. Nonetheless, these results suggest that many aspects of the 25 trajectory of transcriptional changes are shared across the HTT Q-lengths that have been studied. 26 Notably, all of the TFs whose target genes were enriched for differentially expressed genes at the 27 very earliest timepoints were enriched primarily for genes that were down-regulated in HD.
28
Strong enrichments of TF-target gene modules for up-regulated genes occurred only at slightly 29 later time points. 30 31
Genome-wide characterization of SMAD3 binding sites in the mouse striatum supports a 32 role in early gene dysregulation in HD. 33 34 SMAD3 was one of 13 core TFs whose predicted target genes were overrepresented 35 among differentially expressed genes across all four independent datasets. Progressive down-36 regulation of Smad3 mRNA ( Fig. 6a ) and of predicted SMAD3 target genes ( Fig. 5 ) occurred in 37
an age-and Htt-allele-dependent fashion, beginning at or before six postnatal months. 38 We characterized the binding sites of SMAD3 in the striatum of four-month-old Htt Q111 within 10kb of transcription start sites (TSSs), including at least one peak within 10kb of the 44 TSSs for 11,727 genes (Fig. 6b ). The summits of SMAD3 peaks were enriched for the 45 SMAD2:SMAD3:SMAD4 motif (p-value = 7.2e-85; Fig. 6c ). Importantly, the TSSs for 753 of 46 the 938 computationally predicted SMAD3 target genes in our TRN model were located within 1 10kb of at least one ChIP-based SMAD3 binding site. This overlap was significantly greater than 2 expected by chance (odds ratio = 4.33, p-value = 2.8e-84). 3
We characterized the relationship between SMAD3 occupancy and transcriptional 4 activation by measuring the genomic occupancy of RNA Polymerase II (RNAPII) in the striatum 5
of Htt Q111/+ and wildtype mice. RNAPII occupancy is a marker of active transcription and of 6
active transcription start sites. Occupancy of SMAD3 and of RNAPII were positively correlated, 7 across all genomic regions (r = 0.70) and specifically within SMAD3 peaks (r = 0.71). 8
Similarly, we characterized the relationship between SMAD3 occupancy and chromatin 9 accessibility, using publicly available DNase-seq of midbrain tissue from wildtype mice. 22,650 10
of the 57,772 SMAD3 peaks (39.2%) overlapped a DNase hypersensitive site in the midbrain. 11
Occupancy of SMAD3 was positively correlated with DNase-I hypersensitivity across all 12
genomic regions (r = 0.33) and specifically within SMAD3 peaks (r = 0.25).
13
We ranked genes from highest to lowest SMAD3 regulatory potential based on the 14 number of SMAD3 peaks within 10kb of their transcriptional start sites. We focused on the top 15 837 genes with SMAD3 peak counts > 2 standard deviations above the mean. These top 837 16
SMAD3 target genes were enriched (FDR < 0.01) for 24 non-overlapping clusters of Gene 17
Ontology terms (SI Table 1 ). These enriched GO terms prominently featured pathways related to 18 gene regulation ("mRNA processing", p = 4.2e-9; "histone modification", p = 1.7e-7; 19
"transcriptional repressor complex", p = 3.7e-5), as well as functions more specifically related to 20 brain function ("neuromuscular process controlling balance", p = 1.2e-7; "brain development", p 21 = 1.27e-6; "neuronal cell body", p = 2.5e-5).
22
We performed quantitative and qualitative analyses to compare SMAD3 occupancy in 23
Htt Q111/+ vs. wildtype mice. 51,721 of the 57,772 SMAD3 peaks (89.5%) were identified in both 24
Htt Q111/+ and wildtype mice. 5,419 peaks (9.4%) were identified only in wildtype mice, while 25
only 632 peaks (1.1%) were identified only in Htt Q111/+ mice ( Fig. 6d ). Quantitative analyses of 26 differential binding with edgeR revealed four peaks whose occupancy was significantly different 27
(FDR < 0.05) between Htt Q111/+ and wildtype mice. All four of these peaks were more weakly 28
occupied in Htt Q111/+ mice. 138 peaks had nominally significant differences in occupancy 29
between genotypes (p < 0.01). 133 of these 138 peaks (96.4%) were more weakly occupied in 30
Htt Q111/+ mice (Fig. 6e ). These results suggest that SMAD3 occupancy is decreased at a subset of 31
its binding sites in four-month-old Htt Q111/+ mice. 32
Finally, we tested whether the top 837 SMAD3 target genes from ChIP-seq were 33
differentially expressed in HD knock-in mice. The top 837 SMAD3 target genes from ChIP-seq 34
were significantly overrepresented among genes that became down-regulated in the striatum of 35
HD knock-in mice (223 down-regulated SMAD3 target genes; odds ratio = 2.0, p-value = 3.4e-36 15; Fig. 6f ). By contrast, SMAD3 target genes were not overrepresented among genes that 37
became up-regulated in the striatum of HD mouse models (143 up-regulated SMAD3 target 38
genes, odds ratio = 0.92, p = 0.40). These results are consistent with our computational model, in 39 which SMAD3 target genes were primarily down-regulated in HD knock-in mice. Therefore, 40
SMAD3 binding is associated with down regulation in HD mouse models. 41 42
Discussion 43 44
Here, we identified putative core TFs regulating gene expression changes in Huntington's 45
disease by reconstructing genome-scale transcriptional regulatory network models for the mouse 46 and human striatum. Identifying core TFs in HD provides insights into the mechanisms of this 1 devastating, incurable disease. This method to reconstruct models of mammalian transcriptional 2 regulatory networks can be readily applied to find regulators underlying any trait of interest. expressed genes in our model, but only at later time points or more weakly than our top 48 core 20
regulator TFs. 21 Our Replication across four independent datasets revealed 13 TFs whose target genes were 29 most consistently enriched among differentially expressed genes. We propose that these TFs 30
should be prioritized for follow-up experiments, both to validate predicted target genes and to 31 evaluate specific biological functions for each TF. For instance, it will be interesting to 32 determine which (if any) of the core TFs have direct protein-protein interactions with the HTT 33
protein and to test our model's predictions about TF perturbations with specific aspects of HD 34
pathology. The target genes for most of these 13 TFs were enriched for genes that were down-35 regulated in HD and for neuron-specific genes, consistent with the idea that pathological changes 36 originate in medium spiny neurons. 37
Our ChIP-seq data confirm an association between SMAD3 binding sites and genes that 38
are down-regulated in HD. SMAD3 is best known for its role in mediating signaling by 39
Transforming Growth Factor-Beta (TGF-β) signaling (Kandasamy et al, 2011) . Several recent 40 studies have described altered TGF-β signaling in the early stages of HD (Ring et al, 2015; 41 Battaglia et al, 2011). However, to our knowledge a role for SMAD3 has not been described.
42
These findings suggest that intriguing possibility that agonists of TGF-β signaling could have 43 therapeutic benefit in HD patients. Consistent with this possibility, TGF-β treatment has recently 44 been shown to reduce apoptotic cell death in neural stem cells with expanded HTT polyQ tracts 45 (Ring et al, 2015) . 46
Our method to reconstruct TRNs by integrating information about TF occupancy with 1 gene co-expression is likely to be broadly applicable, providing a strategy to optimize both 2 mechanistic and quantitative accuracy. TRN reconstruction methods based purely on gene co-3 expression struggle to distinguish direct vs. indirect interactions. Physical models of TF 4 occupancy provide poor quantitative predictions because many TF binding sites are non-5 functional or do not regulate the nearest gene. Our study demonstrates that integrated TRN 6
modeling can be utilized effectively to study neurodegenerative diseases such as HD, combining 7
data from the ENCODE project with disease specific transcriptome profiling. 8 9
Methods 10 11
Referenced datasets. We obtained RNA-seq and microarray gene expression profiling data from RNA-seq data (GSE65776), we downloaded read counts and FPKM estimates, mapped to 18 ENSEMBL gene models. For Affymetrix microarrays (GSE18551, GSE32417, GSE9038, 19
GSE9857, GSE26927, and GSE3790) we downloaded raw image files and used the affy package 20
in R to perform within-sample RMA normalization and between-sample quantile normalization. 21
For proteomics data, we downloaded MaxQuant protein quantities. 22 23
Genomic footprinting. DNase-I digestion of genomic DNA followed by deep sequencing 24
(DNase-seq) enables the identification of genomic footprints across the complete genome. We 25
predicted genome-wide transcription factor binding sites (TFBSs) in the mouse and human 26
genomes based on instances of TF sequence motifs in digital genomic footprints from the 27 ENCODE project. Short regions of genomic DNA occupied by DNA-binding proteins produce 28 characterizes characteristic "footprints" with altered sensitivity to the DNase-I enzyme. DNase-I 29 digestion of genomic DNA followed by deep sequencing (DNase-seq) enables the identification 30 of genomic footprints across the complete genome.
31
For the human TFBS model, we used a previously described database ( Regression-based transcriptional regulatory network models. We fit a regression model to 1 predict the expression of each gene in mouse or human striatum, based on the expression patterns 2
of TFs that had predicted binding sites within 5kb of that gene's transcription start sites. We 3 applied LASSO regularization to penalize regression coefficients and remove TFs with weak 4 effects, using the glmnet package in R. These methods were optimized across several large 5 transcriptomics datasets, prior to their application to the Huntsington's disease data. To 6 reconstruct the TRN model for mouse striatum, we used RNA-seq data from the striatum of 208 7 mice (Langfelder et al, 2016) . Prior to network reconstruction, we evaluated within and between 8 group variance and detected outlier samples using hierarchical clustering and multidimensional 9
scaling. No major differences in variance were identified between groups, and no outlier samples 10
were detected or removed. 11 We considered a variety of model parameterization during the initial model formulation. 12 We considered elastic net regression and ridge regression as alternatives to LASSO regression. 13
We selected LASSO based on the least falloff in performance from the training data to test sets 14
in five-fold cross-validation. We note that when multiple TFs have correlated expression, the 15 LASSO will generally retain only one for the final model. This feature of the LASSO has been 16 considered advantageous, since it can eliminate indirect interactions. However, there is virtually 17
no doubt that the TFs selected by our model underestimate the true number of TF-target gene 18
interactions. We would only pick up dominant effects where a linear model works reasonably 19
well. Our primary interest is ultimately in using this approach to find a relatively small number 20
of targets based on multiple lines of evidence. We are less concerned with finding everything 21 than in trying to make sure what we do find is as highly enriched for true positives as possible.
22
We also considered a variety of strategies to select an appropriate penalty parameter. For 23 instance, we could apply an independent penalty parameter for each gene, or we could use a 24 uniform penalty parameter across all genes. We found that optimal performance was obtained in 25
both training data and in five-fold cross-validation when we applied a uniform penalty parameter 26 across all genes. We assigned this penalty parameter by evaluating performance in cross-27 validation across a range of possible parameters for a random subset of 100 genes. For each 28
gene, we identified the most stringent penalty such that the unfitted variance was < 1 standard 29 error greater than the minimum unfitted variance across all the penalty parameters considered. 30 We selected the median penalty defined by this procedure across the 100 randomly selected 31 gene.
32
Not all genes' expression can be accurately predicted based on the expression of TFs. To 33
select genes for the final model, we evaluated the variance explained by the model in a training 34 set consisting of 80% of the data. We selected those genes for which the model explained >50% 35
of expression variance in the training set and carried these genes forward to a test set, consisting 36 of the remaining 20% of genes. We found that training set performance accurately predicted test 37 performance (r = 0.94). We therefore fit a final model for genes whose expression could be 38 accurately predicted in the training set. The result of these procedures is a tissue-specific TRN 39
model, predicting the TFs that regulate each gene in the striatum and assigning a positive or 40 negative weight for each TF's effect on that gene's expression in the striatum. 41 42
Enrichments of TF-target gene modules in ChIP-seq data. We downloaded ChIP-seq data 43 from the ENCODE website (encodeproject.org, accessed August 20, 2015) for 33 mouse 44 transcription factors included in our TRN model. We identified genes whose transcription start 45 sites were located within 5kb of a narrowPeak in each ChIP experiment. We also downloaded a 46 Enrichments of TF-target gene modules for Gene Ontology terms. We downloaded Gene 6
Ontology (GO) annotations for mouse genes from GO.db on November 4, 2015, using the 7 topGO R package. We extracted the genes annotated to each GO term and its children, and we 8
used Fisher's exact tests to characterize enrichments of TF-target gene modules for the 4,624 GO 9
terms that contain between 10 and 500 genes. 10 11
Enrichments of TF-target gene modules for cell type-specific genes. We characterized sets of 12 genes expressed in each striatal cell type using gene expression profiles from purified cell types 13
( TF-target gene modules for genes expressed specifically in each cell type. 16 17
Enrichments of TF-target gene modules for differentially expressed genes. We identified 18
genes that were differentially expressed in HD vs. control samples. In the primary dataset, we 19
compared mice with the non-pathogenic Q20 allele and mice with each of the other five alleles, 20
separately for 2-, 6-, and 10-month-old mice. We used the edgeR R package to fit generalized 21 linear models and test for significance of each contrast. We used Fisher's exact tests to 22 characterize enrichments of down-regulated genes and up-regulated genes in each condition 23
(significance threshold for differentially expressed genes, p < 0.01) for the target genes of each 24
TF. We considered enrichments to be statistically significant at a raw p-value threshold < 1e-6, 25
or an adjusted p-value < 0.02 after accounting for 19,170 tests (639 TFs x 5 Htt alleles x 3 time 26 points x 2 tests / condition).
27
To identify top TFs, accounting for non-independence among genes and conditions, we 28
calculated an empirical false discovery rate for these enrichments. We repeated the edgeR and 29 enrichment analyses 1,000 times with permuted sample labels. We found that no module had a p-30
value < 1e-6 in more than four conditions in any of the permuted datasets. Therefore, we focused 31
on TFs whose target genes were overrepresented for differentially expressed genes in five or 32 more conditions. 33
We performed similar analyses to characterize TF-target gene modules enriched for 34
genes that were differentially expressed in replication samples. We used the limma R package to calculated enrichments of the DEGs from each study for TF-target gene modules. We then 38
combined the enrichment p-values across the four studies using Fisher's method to produce a 39 meta-analysis p-value for the association of each TF-target gene module in HD mouse models. 40
We used quantitative proteomics data from 6-month old Htt Q20/+ , Htt Q80/+ , Htt Q92/+ , 41
Htt Q111/+ , Htt Q140/+ and Htt Q175/+ mice (n = 8 per group) (Langfelder et al, 2016) . We 42 characterized proteins whose abundance was correlated with Htt CAG length in the striatum of 43 6-month-old mice, using MaxQuant protein quantities. We then calculated enrichments of CAG-44
length correlated proteins (Pearson correlation, p < 0.01) for each TF-target gene module with 45
Fisher's exact test, separately for proteins whose abundance was positively or negatively 1 correlated with CAG length. 2 We used the limma R package to fit a linear model to characterize differentially 3 expressed genes in each of two microarray datasets (Hodges et al, 2006; Durrenberger et al, 4 2015) profiling dorsal striatum of HD cases vs. controls, treating sex as a covariate. We 5 calculated enrichments of the DEGs from each study for TF-target gene modules. We then 6
combined the enrichment p-values across the two studies using Fisher's method to produce a 7 meta-analysis p-value for the association of each TF-target gene module with HD. 8 9
Mouse Breeding, Genotyping, and microdissection. The B6.Htt Q111/+ mice (Strain 003456; JAX) 10
used for the ChIP-seq study have a targeted mutation replacing a portion of mouse Htt (formerly 11
Hdh) exon 1 with the corresponding portion of human HTT (formerly IT15) exon 1, including an 12
expanded CAG tract (originally 109 repeats). Mice used in the present study were on the 13 C57BL/6J inbred strain background. The targeted Htt allele was placed from the CD-1 14
background onto the C57BL/6J genetic background by selective backcrossing for more than 10 15
generations to the C57BL/6J strain at Jackson laboratories. Cohorts of heterozygote and wild-16
type littermate mice were generated by crossing B6.Htt Q111/+ and B6.Htt +/+ mice. Male mice were 17
sacrificed at 122 ± 2 days of age (or 16 weeks) via a sodium phenobarbital based euthanasia 18 solution (Fatal Plus, Henry Schein). Both hemispheres of each animal's brain was microdissected 19
on ice into striatum, cortex, and remaining brain regions. These tissues were snap frozen and 20 stored in -80°C. Experiments were approved by an institutional review board in accordance with 21
NIH animal care guidelines.
23
High resolution X-ChIP-seq. We prepared duplicate ChIP samples for each antibody from four-24 month-old Htt Q111/+ and from age-matched wildtype mice. For each ChIP preparation, chromatin 25
DNA was prepared using the combined striatal tissue from both hemispheres of three mice. 26 Preliminary experiments suggested that this was the minimal amount of material required to 27 provide enough material for multiple IPs. Striata were transferred to a glass dounce on ice and 28 homogenized in cold PBS with protease inhibitors. High-resolution X-ChIP-seq was performed 29
as described (Skene et al, 2010) , with slight modifications. IPs were performed using Abcam 30
Anti-SMAD3 antibody ab28379 [ChIP grade] or Anti-RNA polymerase II CTD repeat 31
YSPTSPS antibody [8WG16] [ChIP Grade] ab817. Sequencing libraries were prepared from the 32 isolated ChIP DNA and from input DNA controls as previously described (Orsi et al, 2015) . 33 Libraries were sequenced on an Illumina HiSeq 2500 sequencer to a depth of ~17-25 million 34
paired-end 25 bp reads per sample. Sequence reads have been deposited in GEO, accession 35
GSE88775. 36 37
ChIP-seq analysis. Sequencing reads were aligned to the mouse genome (mm9) using bowtie2 38 (Langmead & Salzberg, 2012) . Peak-calling on each sample was performed with MACS v2.1 39 (Zhang et al, 2008) , scaling each library to the size of the input DNA sequence library to 40 improve comparability between samples. We retained peak regions with a significant MACS p-41 value (FDR < 0.01 and a read count ≥10 in at least two of the individual ChIP samples).
42
Enrichment of the SMAD3 motif (JASPAR CORE MA0513.1) was performed with CentriMo 43
(Bailey & Machanick, 2012), using the 250bp regions around peak summits obtained by running 44
MACS on the combined reads from all the samples. Peaks were mapped to genes using the 45 chipenrich R package (Welch et al, 2014) , and genes were ranked by the number of peaks within 46 10kb of each gene's transcription start sites. Gene Ontology enrichment analysis of the top 1 SMAD3 target genes (peak counts >2 s.d. above the mean), was performed using Fisher's exact 2 test, using the same set of GO terms used to analyze the computationally derived TF-target gene 3
modules. Statistical analysis of differential occupancy in Htt Q111/+ vs. wildtype mice was 4 performed with edgeR (Robinson et al, 2010 This work was supported by a contract from the CHDI Foundation (N.D.P., Principal 16 Investigator and J.B.C, Principal Investigator). J.R.P. is supported by a National Science 17
Foundation Graduate Research Fellowship. J.B.C. is supported by Huntington Society of 18
Canada New Pathways Program. 19 20 Conflict of Interests 21 22
The authors declare that they have no conflict of interest. 23 24 (black) and test set (blue) prediction accuracy for genes in the mouse striatum TRN model. 6
Figure Legends
Genes are ordered on the x-axis according to their training set prediction accuracy (r 2 , predicted 7
vs. actual expression). c. Distribution for the number of predicted regulators per target gene. d. 8
Distribution for the number of predicted target genes per TF. e. Enrichments of TF-target gene 9
interactions in the mouse striatum TRN for TFBSs supported by DNase footprints identified in 10 23 tissues. Distance to TSS (kb) Proportion of Peaks for the number of predicted regulators per target gene. c. Distribution for the number of predicted 31 target genes per TF. d. Enrichment of down-regulated core regulator TFs identified in mouse 32 striatum for down-regulated genes in HD cases vs. controls. e. Enrichment of up-regulated core 33
regulator TFs identified in mouse striatum for up-regulated genes in HD cases vs. controls. 
